195 related articles for article (PubMed ID: 37966272)
1. Recombinant duck enteritis virus bearing the hemagglutinin genes of H5 and H7 influenza viruses is an ideal multivalent live vaccine in ducks.
Zhao Y; Chen P; Hu Y; Liu J; Jiang Y; Zeng X; Deng G; Shi J; Li Y; Tian G; Liu J; Chen H
Emerg Microbes Infect; 2024 Dec; 13(1):2284301. PubMed ID: 37966272
[TBL] [Abstract][Full Text] [Related]
2. A duck enteritis virus-vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks.
Liu J; Chen P; Jiang Y; Wu L; Zeng X; Tian G; Ge J; Kawaoka Y; Bu Z; Chen H
J Virol; 2011 Nov; 85(21):10989-98. PubMed ID: 21865383
[TBL] [Abstract][Full Text] [Related]
3. Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens.
Wang J; Ge A; Xu M; Wang Z; Qiao Y; Gu Y; Liu C; Liu Y; Hou J
Virol J; 2015 Aug; 12():126. PubMed ID: 26263920
[TBL] [Abstract][Full Text] [Related]
4. Recombinant duck enteritis virus expressing the HA gene from goose H5 subtype avian influenza virus.
Liu X; Wei S; Liu Y; Fu P; Gao M; Mu X; Liu H; Xing M; Ma B; Wang J
Vaccine; 2013 Dec; 31(50):5953-9. PubMed ID: 24144474
[TBL] [Abstract][Full Text] [Related]
5. Efficient strategy for constructing duck enteritis virus-based live attenuated vaccine against homologous and heterologous H5N1 avian influenza virus and duck enteritis virus infection.
Zou Z; Hu Y; Liu Z; Zhong W; Cao H; Chen H; Jin M
Vet Res; 2015 Apr; 46(1):42. PubMed ID: 25889564
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
[TBL] [Abstract][Full Text] [Related]
7. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
[TBL] [Abstract][Full Text] [Related]
8. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
[TBL] [Abstract][Full Text] [Related]
9. Construction of a recombinant duck enteritis virus vaccine expressing hemagglutinin of H9N2 avian influenza virus and evaluation of its efficacy in ducks.
Sun Y; Yang C; Li J; Li L; Cao M; Li Q; Li H
Arch Virol; 2017 Jan; 162(1):171-179. PubMed ID: 27709401
[TBL] [Abstract][Full Text] [Related]
10. Protective efficacy of an inactivated chimeric H7/H5 avian influenza vaccine against highly pathogenic avian influenza H7N9 and clade 2.3.4.4 H5 viruses.
Peng C; Hou G; Li J; Wang S; Wang Y; Cheng S; Yu X; Jin J; Jiang W
Vet Microbiol; 2018 Sep; 223():21-26. PubMed ID: 30173747
[TBL] [Abstract][Full Text] [Related]
11. Genetic and antigenic characterization of H5 and H7 avian influenza viruses isolated from migratory waterfowl in Mongolia from 2017 to 2019.
Ulaankhuu A; Bazarragchaa E; Okamatsu M; Hiono T; Bodisaikhan K; Amartuvshin T; Tserenjav J; Urangoo T; Buyantogtokh K; Matsuno K; Hattori T; Kondoh T; Sato M; Takadate Y; Torii S; Isono M; Okuya K; Saito T; Kasajima N; Kida Y; Maruyama J; Igarashi M; Takada A; Kida H; Batchuluun D; Sakoda Y
Virus Genes; 2020 Aug; 56(4):472-479. PubMed ID: 32430568
[TBL] [Abstract][Full Text] [Related]
12. Protective efficacy in farmed ducks of a duck enteritis virus-vectored vaccine against H5N1, H5N6, and H5N8 avian influenza viruses.
Chen P; Ding L; Jiang Y; Zeng X; Deng G; Shi J; Li Y; Liu L; Zhao Y; Hu Y; Liu J; Chen H
Vaccine; 2019 Sep; 37(40):5925-5929. PubMed ID: 31471151
[TBL] [Abstract][Full Text] [Related]
13. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
[TBL] [Abstract][Full Text] [Related]
14. Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.
Kapczynski DR; Pantin-Jackwood MJ; Spackman E; Chrzastek K; Suarez DL; Swayne DE
Vaccine; 2017 Nov; 35(46):6345-6353. PubMed ID: 28456525
[TBL] [Abstract][Full Text] [Related]
15. Role of the Hemagglutinin Residue 227 in Immunogenicity of H5 and H7 Subtype Avian Influenza Vaccines in Chickens.
Hu Z; Shi L; Zhao J; Gu H; Hu J; Wang X; Liu X; Hu S; Gu M; Cao Y; Liu X
Avian Dis; 2020 Dec; 64(4):445-450. PubMed ID: 33347548
[TBL] [Abstract][Full Text] [Related]
16. H5-based DNA constructs derived from selected highly pathogenic H5N1 avian influenza virus induce high levels of humoral antibodies in Muscovy ducks against low pathogenic viruses.
Guionie O; Niqueux E; Amelot M; Bougeard S; Jestin V
Virol J; 2014 Apr; 11():74. PubMed ID: 24762011
[TBL] [Abstract][Full Text] [Related]
17. Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.
Niqueux E; Guionie O; Amelot M; Jestin V
Vaccine; 2013 Aug; 31(38):4121-8. PubMed ID: 23845804
[TBL] [Abstract][Full Text] [Related]
18. Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses.
Liu Q; Mena I; Ma J; Bawa B; Krammer F; Lyoo YS; Lang Y; Morozov I; Mahardika GN; Ma W; García-Sastre A; Richt JA
J Virol; 2015 Jul; 89(14):7401-8. PubMed ID: 25926639
[TBL] [Abstract][Full Text] [Related]
19. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
[TBL] [Abstract][Full Text] [Related]
20. Construction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infection.
Zou Z; Huang K; Wei Y; Chen H; Liu Z; Jin M
Sci Rep; 2017 May; 7(1):1478. PubMed ID: 28469192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
